Thursday, July 11, 2024
Opening
Harold Burstein, MD, PhD
Innovation in Breast Conserving Surgery
Barbara Smith, MD, PhD
Surgical Management of the Axilla
Tari King, MD, FACS
Reconstructive Surgery Update
Justin Broyles, MD
Q&A
The Future of Pathology in Breast Cancer
Stuart Schnitt, MD
Innovations in Breast Imaging
Maxine Jochelson, MD
Q&A
Break
Navigating Family Issues in Familial Breast Cancer
Brittany Bychkovsky, MD, MSc
Surgical Management of Hereditary Breast Cancer
Laura Dominici
Systemic Therapy for Hereditary Breast Cancer
Filipa Lynce, MD
Q&A
Break (Pick Up Lunch)
Tumor Board: Local Regional Therapy (Lunch Provided)
TBD
Break
ctDNA - What Evidence Do We Need?
Heather Parsons, MD, MPH
Targeting ER with SERDS and PROTACS
Rinath Jeselsohn, MD
Inhibiting the PIK3CA and AKT Pathways
Alex Toker, PhD
CDK4/6 As a Target in Early and Late Breast Cancer
Erica Mayer, MD, MPH
Immunotherapy for ER+ Breast Cancer
Elizabeth Mittendorf, MD, PhD
Q&A
Break
Sentinel Node Omission: Who is the Best Candidate, and What are the Implications for Radiation?
Rinaa Punglia, MD, MPH; Ko Un “Clara” Park, MD
Regional Nodal Irradiation: Indications and Strategies
Rachel Jimenez, MD
Q&A
Tumor Board: Early Breast Cancer
Beverly Moy, MD, MPH; Sara Tolaney, MD, MPH
Adjourn and Reception
Friday, July 12, 2024
Treatment of HER2 Positive Metastatic Breast Cancer
Sarah Sammons, MD
Management of CNS Disease
Nancy Lin, MD
ER+ Metastatic Breast Cancer: Integrating the Options
Daniel Abravanel, MD, PhD
Innovations in Advanced Triple Negative Breast Cancer
Ana Garrido-Castro, MD
Q&A
Systemic Therapy for ER+ Cancers
Leticia Varella
Treating High- and Low-Risk HER2+ Early Breast Cancer
TBD
Triple Negative Breast Cancer
Laura Spring, MD
Break
Male Breast Cancer
Jose Leone, MD
Breast Cancer and the Elderly
Rachel Freedman, MD, MPH
Q&A
ASCO Highlights
Harold Burstein, MD, PhD
Break (Pick Up Lunch)
Advanced Breast Cancer Tumor Board (Lunch Provided)
Beverly Moy, MD, MPH; Sara Tolaney, MD, MPH
Break
TBD
Aleix Pratt, MD, PhD
Q&A
Pregnancy and Breast Cancer
Ann Partridge, MD, MPH
Integrative Therapy for Symptom Management
Ting Bao, MD
Understanding Financial Toxicity in Young Adults with Breast Cancer
Sara Myers, MD
Q&A
Break
Escalating/De-escalating: Where We Are Going in Breast Cancer
Harold Burstein, MD, PhD
Important Ongoing Clinical Trials
Antonio Giordano, MD, PhD
Supportive Care During Chemotherapy
Elahe Salehi, DNP, ANP-BC
Sexual Health after Breast Cancer Treatment
Sharon Bober, PhD
Patient Advocates
Christine McLaughlin; Paula Steeves
Panel Discussion
Harold Burstein, MD, PhD; Antonio Giordano, MD, PhD; Elahe Salehi, DNP, ANP-BC; Sharon Bober, PhD; Christine McLaughlin; Paula Steeves
Closing Remarks and Adjourn
Harold Burstein, MD, PhD